Patients with IBD had a higher risk for myocarditis, especially severe myocarditis, than the general population, according to the results of a Swedish Cohort Study.
Bristol Myers Squibb said on Thursday its experimental drug to treat Crohn's disease, a chronic inflammatory bowel condition, did not help patients achieve disease remission.
Anti-TNF therapy alone was noninferior to a combination of surgery and anti-TNF therapy in fistula healing in patients with perianal fistulizing Crohn's, a meta-analysis showed.